Although research indicates that changes in the GABAergic system are involved in PD, our study did not find significant differences in GAD1 blood levels between the PD patients and controls, suggesting that it may not be a reliable biomarker for the disease. This evidence concerns the gene GAD1 and Parkinson disease.